Reduction of Chemokine Secretion in Response to Mycobacteria in Infliximab-Treated Patients

The use of anti-tumor necrosis factor (TNF) agents as a treatment for chronic inflammatory conditions has been shown to be associated with an increased risk of developing tuberculosis. We studied the effect of the anti-TNF antibody infliximab on antimycobacterial immunity in 26 patients with rheumat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Newton, Sandra M., Mackie, Sarah L., Martineau, Adrian R., Wilkinson, Katalin A., Kampmann, Beate, Fisher, Corinne, Dutta, Shouma, Levin, Michael, Wilkinson, Robert J., Pasvol, Geoffrey
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology (ASM) 2008
Assuntos:
Microbial Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2268261/
https://ncbi.nlm.nih.gov/pubmed/18160618
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00401-07
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados